Six inventors registered an AI-powered, dual-mode SpO2 wearable (Design 202514911) optimizing blood oxygen monitoring for ...

Pulse oximetry guides the management of respiratory conditions through non-invasively monitoring arterial oxygen saturation. Unstable haemoglobin variants may produce inaccurate readings. We describe ...

This scale gives Danaher the muscle to build bioprocessing systems, precision laboratory instruments, genomic technologies, ...

Market Overview and Growth OutlookThe global mHealth monitoring and diagnostic medical devices market is poised for strong expansion, projected to register a robust compound annual growth rate of ...

Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider ...

The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale ...

Masimo supplies noninvasive monitoring tech to hospitals and care providers, serving both medical and consumer health markets worldwide.

Diagnostics business unit News of the agreement sent Masimo’s Nasdaq-listed stock price up in value by more than 30 per cent, with the $180-per-share purchase price last achieved just under a year ago ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...

For those who like to run the numbers, Danaher claims it is paying “18x estimated 2027 EBITDA, or 15x 2027 estimated EBITDA ...

Danaher Corp. announced Tuesday it will acquire Masimo Corp. in a blockbuster $9.9 billion transaction, including debt, a move set to reshape the global diagnostics landscape. Kirkland & Ellis LLP is ...

Danaher Corporation, a global science and technology company, has entered into a definitive agreement to acquire Masimo Corporation, a specialty diagnostics provider of pulse oximetry and ...